1. Home
  2. KLTOW vs HUBCW Comparison

KLTOW vs HUBCW Comparison

Compare KLTOW & HUBCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • HUBCW
  • Stock Information
  • Founded
  • KLTOW N/A
  • HUBCW N/A
  • Country
  • KLTOW United States
  • HUBCW Israel
  • Employees
  • KLTOW 3
  • HUBCW 322
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • HUBCW
  • Sector
  • KLTOW Health Care
  • HUBCW
  • Exchange
  • KLTOW Nasdaq
  • HUBCW Nasdaq
  • Market Cap
  • KLTOW N/A
  • HUBCW N/A
  • IPO Year
  • KLTOW 2022
  • HUBCW N/A
  • Fundamental
  • Price
  • KLTOW $0.25
  • HUBCW $0.02
  • Analyst Decision
  • KLTOW
  • HUBCW
  • Analyst Count
  • KLTOW 0
  • HUBCW 0
  • Target Price
  • KLTOW N/A
  • HUBCW N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • HUBCW N/A
  • Earning Date
  • KLTOW N/A
  • HUBCW N/A
  • Dividend Yield
  • KLTOW N/A
  • HUBCW N/A
  • EPS Growth
  • KLTOW N/A
  • HUBCW N/A
  • EPS
  • KLTOW N/A
  • HUBCW N/A
  • Revenue
  • KLTOW N/A
  • HUBCW N/A
  • Revenue This Year
  • KLTOW N/A
  • HUBCW N/A
  • Revenue Next Year
  • KLTOW N/A
  • HUBCW N/A
  • P/E Ratio
  • KLTOW N/A
  • HUBCW N/A
  • Revenue Growth
  • KLTOW N/A
  • HUBCW N/A
  • 52 Week Low
  • KLTOW N/A
  • HUBCW N/A
  • 52 Week High
  • KLTOW N/A
  • HUBCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • HUBCW N/A
  • Support Level
  • KLTOW N/A
  • HUBCW N/A
  • Resistance Level
  • KLTOW N/A
  • HUBCW N/A
  • Average True Range (ATR)
  • KLTOW 0.00
  • HUBCW 0.00
  • MACD
  • KLTOW 0.00
  • HUBCW 0.00
  • Stochastic Oscillator
  • KLTOW 0.00
  • HUBCW 0.00

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: